Low-dose letrozole-HMG regimen reverses letrozole-induced endometrial impairment and improves frozen embryo transfer outcomes. [PDF]
Xiao Z +9 more
europepmc +1 more source
Endocrine Therapy for Endometrial Carcinoma: Current Evidence, Resistance Mechanisms, and Biomarker-Driven Patient Selection. [PDF]
Yamanaka T +4 more
europepmc +1 more source
Efficacy of sequential letrozole and gonadotropin therapy for ovulation induction in women with polycystic ovary syndrome: a systematic review and meta-analysis. [PDF]
Sajjad W +11 more
europepmc +1 more source
Integrative Approaches to Ovulation Induction in Polycystic Ovary Syndrome: A Narrative Review of Conventional and Complementary Therapies. [PDF]
Song SY.
europepmc +1 more source
Beyond Chemotherapy: Network Meta-Analysis Reveals Optimal Neoadjuvant Strategies for Luminal Breast Cancer. [PDF]
Li X, Du P, Huang T.
europepmc +1 more source
Grade 3 Dermatitis Secondary to Two Aromatase Inhibitors in Early Hormone Receptor-Positive Breast Cancer: A Case Report. [PDF]
Gayford K +3 more
europepmc +1 more source
Grade II obesity is an independent predictor of poor response to ovulation induction with oral letrozole in infertile women with PCOS: A prospective cohort study from North India. [PDF]
Tholiya S +7 more
europepmc +1 more source
Related searches:
Aromatase is an enzyme which converts adrenal androgens to estrogens in postmenopausal women. Given the importance of estrogens in breast cancer growth, aromatase inhibitors are used to treat breast cancer in different settings. This review focuses on letrozole, a third generation aromatase inhibitor, encompassing pharmacodynamic and pharmacokinetic ...
Silvia, Dellapasqua, Marco, Colleoni
openaire +3 more sources

